SURGICAL COMPLICATIONS OF CYSTIC FIBROSIS IN PEDIATRIC PRACTICE
DOI:
https://doi.org/10.32782/2226-2008-2025-3-13Keywords:
cystic fibrosis, surgical complications, intestinal obstruction, bezoar, surgical treatmentAbstract
Introduction. Cystic fibrosis is one of the world’s most widespread hereditary fatal diseases, which are characteristic of representatives of the white race. Cystic fibrosis is a systemic, genetically determined, autosomal recessive disease characterized by damage to the exocrine glands.The aim is to demonstrate the importance of early diagnosis and treatment of surgical complications of cystic fibrosis in children.Materials and methods. The analysis and generalization of the results of scientific research selected on the basis of an information search in the scientometric databases Scopus, Web of Science, PubMed, MEDLINE, and Google Scholar.The clinical manifestation can vary depending on the exact location of the bezoar and its composition; the diagnosis can be made using CT with contrast enhancement. The formation of fistulas, ulcers, and adhesions are recurrent complications, and severe cases are quite rare.The appearance of a bezoar against the background of cystic fibrosis is primarily associated with insufficiency of the exocrine function of the pancreas, violation of the rheological properties of bile, and violation of the function of the mucous membrane of the gastro-intestinal tract. Patients with cystic fibrosis should not use products that have astringent properties. First of all, such a product is the fruit of a persimmon, which can cause obturation obstruction in the form of a diopsirobezoar even in people without cystic fibrosis.Conclusions. Cystic fibrosis is a multisystem disease that primarily affects the respiratory and digestive systems. However, in pediatric surgical practice, special attention is given to surgical complications. Therefore, when symptoms such as abdominal pain and vomiting occur, prompt evaluation by a pediatric surgeon is essential. In cases where signs of partial intestinal obstruction due to cystic fibrosis are present, initial treatment may consist of conservative therapy, including the use of fibrogastroduodenoscopy. If signs of complete obstructive intestinal obstruction develop, or if conservative methods prove ineffective and the obstruction cannot be resolved endoscopically, surgical intervention remains the only effective treatment.
References
Ong T, Ramsey BW. Cystic fibrosis: a review. Jama. 2023; 329(21): 1859–1871. https://doi.org/10.1001/jama.2023.8120.
Taylor-Cousar JL, Robinson PD, Shteinberg M, Downey DG. CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis. The Lancet. 2023; 402(10408): 1171–1184. https://doi.org/10.1016/s0140-6736(23)01609-4.
Berezenko VS, Reznikov YuP, Krat VV. Mukovistsydoz u ditei. Svoiechasna diahnostyka yak vazhlyvyi predyktor efektyvnosti likuvannia (klinichnyi vypadok) [Cystic fibrosis in children. Early diagnosis as an important predictor of treatment efficiency (clinical case)] Perinatolohiia y pediatriia. Ukraina. 2017; 3(71): 74–80. https://doi.org/10.15574/ pp.2017.71.74 (in Ukrainian).
Allen L, Allen L, Carr SB, et al. Future therapies for cystic fibrosis. Nature communications. 2023; 14(1): 693. https://doi.org/10.1038/s41467-023-36244-2.
Scotet V, L’hostis C, Férec C. The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery. Genes. 2020; 11(6): 589. https://doi.org/10.3390/genes11060589.
Moliteo E, Sciacca M, Palmeri A, et al. Cystic fibrosis and oxidative stress: the role of CFTR. Molecules. 2022; 27(16): 5324. https://doi.org/10.3390/molecules27165324.
López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, et al. Cystic fibrosis: current concepts. Boletín médico del Hospital Infantil de México. 2021; 78(6): 584–596. https://doi.org/10.24875/bmhim.20000372.
Bierlaagh MC, Muilwijk D, Beekman JM, van der Ent CK. A new era for people with cystic fibrosis. European Journal of Pediatrics. 2021; 180(9): 2731–2739. https://doi.org/10.1007/s00431-021-04168-y.
Berg P, Jeppesen M, Leipziger J. Cystic fibrosis in the kidney: new lessons from impaired renal HCO3− excretion. Current Opinion in Nephrology and Hypertension. 2021; 30(4): 437–443. https://doi.org/10.1097/mnh.0000000000000725.
Chandler NJ, Ahlfors H, Drury S, et al. Noninvasive prenatal diagnosis for cystic fibrosis: implementation, uptake, outcome, and implications. Clinical Chemistry. 2020; 66(1): 207–216. https://doi.org/10.1373/clinchem.2019.305011.
Stanford GE, Dave K, Simmonds NJ. Pulmonary exacerbations in adults with cystic fibrosis: a grown-up issue in a changing cystic fibrosis landscape. Chest. 2021; 159(1): 93–102. https://doi.org/10.1016/j.chest.2020.09.084.
Kelly J, Al-Rammahi M, Daly K, et al. Alterations of mucosa-attached microbiome and epithelial cell numbers in the cystic fibrosis small intestine with implications for intestinal disease. Scientific Reports. 2022;12(1): 6593. https://doi.org/10.1038/s41598-022-10328-3.
Tobias J, Tillotson M, Maloney L, Fialkowski E. Meconium Ileus, Distal Intestinal Obstruction Syndrome, and Other Gastrointestinal Pathology in the Cystic Fibrosis Patient. The Surgical clinics of North America. 2022; 102(5): 873–882. https://doi.org/10.1016/j.suc.2022.07.016.
Mazur OH, Rubina OS, Bertsun KT, Homon RO, Slipchuk KI. Osoblyvosti mukovistsydozu u novonarodzhenykh na prykladi klinichnoho vypadku [Features of cystic fibrosis in newborns on the example of a clinical case]. Neonatolohiia, khirurhiia ta perynatalna medytsyna. 2022; 12(3(45)): 89–93. (In Ukrainian). https://doi.org/10.24061/2413-4260.XII.3.45.2022.14.
Niemkovych VV, Huk OIu, Korolenko HS, Riznyk AV. Literaturnyi ohliad ta morfolohichni osoblyvosti mukovystsydozu na prykladi klinichnoho vypadku [Literature review and morphological features of cystic fibrosis on the example of a clinical case]. Novyiny i perspectyvy medyichnoyi nauky: Materialy XXI naukovoi konferentsii studentiv ta molodykh uchenykh – Materials of the XXI scientific conference of students and young scientists. 2021. Dnipro, Ukraine (in Ukrainian).
Kasper VL, Assis DN. Pathophysiology of cystic fibrosis liver disease. Pediatric Pulmonology. 2024; 59: 98–106. https://doi.org/10.1002/ppul.26869
Kutney KA, Sandouk Z, Desimone M, Moheet A. Obesity in cystic fibrosis. Journal of Clinical & Translational Endocrinology. 2021; 26: 100276. https://doi.org/10.1016/j.jcte.2021.100276.
Kfouri CFDA, Romania MCFN, Julião RJM, et al. Colonic phytobezoar. Journal of Coloproctology (Rio de Janeiro). 2018; 38: 246–249. https://doi.org/10.1016/j.jcol.2018.02.002.
Ying CL, Zha J, Liu W. Small Bowel Obstruction by Phytobezoar. Digestive Diseases and Sciences. 2024; 70: 1–4. https://doi.org/10.1007/s10620-024-08763-5.
Kosmidis CS, Mystakidou CM, Varsamis N, Koulouris C, Sevva C, Papadopoulou K, Mantalovas S. Phytobezoar-Induced Mechanical Ileus and Incipient Intussusception: A Case Report. Medicina. 2023; 59(7): 1227. https://doi.org/10.3390/medicina59071227.
Aydin I, Sengul I, Sengul D. Phytobezoar: an unusual condition leading to small bowel obstruction. Cureus. 2022; 14(4): e23885 https://doi.org/10.7759/cureus.23885.
Vilela JC, Leal ACC, Laia MG, et al. Abdome Agudo Obstrutivo: Relato de Fitobezoar Causado por Damasco. Journal of Coloproctology. 2021; 41(S 01): A439. https://doi.org/10.1055/s-0041-1742024.
Padilha de Toledo A, Hurtado Rodrigues F, Rocha Rodrigues M, et al. Diospyrobezoar as a cause of small bowel obstruction. Case reports in gastroenterology. 2012; 6(3): 596–603. https://doi.org/10.1159/000343161.
Dubkovska MV, Khimenko TM, Kochkariov OV, Fedorenko OV. Bezoar in the practice of general practitioner and pedia- trician: clinical case – Rapunzel syndrome. Odesa Medical Journal. 2021; (5): 65–70. (In Ukrainian). http://files.odmu.edu.ua/journal/OMJ_2021.05/m215_65.pdf.
Kravets O, Svistunov O, Moskalenko R. A rare case of Meckel’s diverticulum strangulation complicated by small intes- tine obstruction (clinical case). Eastern Ukrainian Medical Journal. 2024; 12(2): 457–465. https://doi.org/10.21272/eumj.2024;12(2):457-465.
Taha Y, Salman K, Alrayyes F, Alrayyes S. An unusual case of phytobezoar-induced small bowel obstruction. Journal of Surgical Case Reports. 2019; (11): 296. https://doi.org/10.1093/jscr/rjz296.
Mejri A, Trigui E. Phytobezoar: A train can hide another. International Journal of Surgery Case Reports. 2021; 81: 105814. https://doi.org/10.1016/j.ijscr.2021.105814.
Jain SA, Agarwal L, Khyalia A, Chandolia P, Kaknale H. Pharmacobezoar – a rare case presented as gastric outlet obstruction. Journal of Surgical Case Reports. 2018; (5): 116. https://doi.org/10.1093/jscr/rjy116.
Ben-Porat T, Dagan SS, Goldenshluger A, Yuval JB, Elazary R. Gastrointestinal phytobezoar following bariatric surgery: systematic review. Surgery for Obesity and Related Diseases. 2016; 12(9): 1747–1754. https://doi.org/10.1016/j.soard.2016.09.003.
Drevin G, Malbranque S, Jousset N, et al. Pharmacobezoar-Related Fatalities: A Case Report and a Review of the Literature. Therapeutic Drug Monitoring. 2022; 46(1): 10–1097. https://doi.org/10.1097/ftd.0000000000001150.
Kumar N, Huda F, Gupta R, Payal YS, Kumar U, Mallik D. Rapunzel syndrome in adult with mysterious presentation: a rare case report with literature review. Tropical Doctor. 2019; 49(2): 133–135. https://doi.org/10.1177/0049475519826477.
Basílio F, Dinis-Oliveira RJ. Clinical and forensic aspects of pharmacobezoars. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews. 2020: 12(2); 118–130.
Zello A, Kirschner D. Diagnosis of a rare pediatric case of small-bowel obstruction secondary to a phytobezoar in a Meckel’s diverticulum aided by point-of-care ultrasound. Canadian Journal of Emergency Medicine. 2023; 25(3): 244–247. https://doi.org/10.1007/s43678-023-00463-9.
